1.97
-0.05 (-2.48%)
-0.05 (-2.48%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -2.48% | 1.97 | 17:37:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.04 | 1.94 | 2.06 | 1.97 | 2.02 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.96 | 1.97 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,451 | 7,518,788 | $ 1.99 | $ 14,930,696 | 9,103,172 | 0.91 - 10.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:37:23 | 1 | $ 1.965 | USD |
Corbus Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 165.55M | 84.04M | 68.54M | $ 36.14M | $ - | -1.13 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Corbus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.7524 | 2.36 | 1.66 | 2.18 | 15,368,445 | 0.2176 | 12.42% |
| 1 Month | 1.26 | 2.36 | 1.22 | 1.81 | 9,564,655 | 0.71 | 56.35% |
| 3 Months | 1.03 | 2.36 | 1.01 | 1.56 | 7,327,767 | 0.94 | 91.26% |
| 6 Months | 6.95 | 10.75 | 0.91 | 2.11 | 5,746,390 | -4.98 | -71.65% |
| 1 Year | 6.59 | 10.75 | 0.91 | 2.89 | 3,444,992 | -4.62 | -70.11% |
| 3 Years | 8.90 | 10.75 | 0.91 | 4.16 | 1,748,454 | -6.93 | -77.87% |
| 5 Years | 1.43 | 10.78 | 0.91 | 4.82 | 1,345,419 | 0.54 | 37.76% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
